These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38046430)

  • 1. Retrospective evaluation of toceranib phosphate (Palladia) use in the treatment of feline pancreatic carcinoma.
    Rosario CO; Musser ML; Yuan L; Mochel JP; Talbott J; Johannes CM; Berger EP
    Can Vet J; 2023 Dec; 64(12):1143-1148. PubMed ID: 38046430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.
    Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N
    J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasia.
    Berger EP; Johannes CM; Post GS; Rothchild G; Shiu KB; Wetzel S; Fox LE
    J Feline Med Surg; 2018 Feb; 20(2):95-102. PubMed ID: 29172873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
    Olmsted GA; Farrelly J; Post GS; Smith J
    J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
    Musser ML; Johannes CM
    BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of toceranib phosphate in cats with macroscopic mammary adenocarcinoma.
    Del Portillo Miguel I; Blackwood L; Maiques E; Pérez Roger I; Poch Jiménez E; Borrego J
    J Feline Med Surg; 2024 Aug; 26(8):1098612X241256473. PubMed ID: 39212426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.
    Merrick CH; Pierro J; Schleis SE; Sones EA; Wright ZM; Regan RC; Siedlecki CT; Bergman PJ
    Vet Comp Oncol; 2017 Sep; 15(3):710-717. PubMed ID: 27041701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and response in cats with neoplasia treated with toceranib phosphate.
    Harper A; Blackwood L
    J Feline Med Surg; 2017 Jun; 19(6):619-623. PubMed ID: 27090289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs.
    Berger EP; Johannes CM; Jergens AE; Allenspach K; Powers BE; Du Y; Mochel JP; Fox LE; Musser ML
    J Vet Intern Med; 2018 Nov; 32(6):2045-2053. PubMed ID: 30307656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical control of feline pancreatic carcinoma with toceranib phosphate.
    Dedeaux AM; Langohr IM; Boudreaux BB
    Can Vet J; 2018 Jul; 59(7):751-754. PubMed ID: 30026621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
    Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
    Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and trends of proteinuria, azotemia and hypertension in cats receiving toceranib phosphate.
    Williams K; MacDonald-Dickinson V; Matsuyama A
    J Feline Med Surg; 2024 Sep; 26(9):1098612X241266418. PubMed ID: 39287178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma.
    Hicks KA; Leeper HJ; Curran KM
    Vet Comp Oncol; 2024 Jun; 22(2):245-254. PubMed ID: 38622074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose meloxicam is safe and tolerable when combined with toceranib phosphate in cancer-bearing cats.
    Keepman SJ; Pellin MA
    J Feline Med Surg; 2022 Dec; 24(12):1187-1194. PubMed ID: 34923878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report.
    Fuertes-Recuero M; Vázquez-Fernández E; Lizasoain-Sánz G; Arroba-Alonso A; Sánchez-López A; Martínez-de-Merlo E; Suárez-Redondo M; Ortiz-Diez G
    Vet Res Commun; 2024 Jun; 48(3):1921-1927. PubMed ID: 38453822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
    Musser ML; Taikowski KL; Johannes CM; Bergman PJ
    BMC Vet Res; 2018 Sep; 14(1):272. PubMed ID: 30176869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
    Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
    J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
    London C; Mathie T; Stingle N; Clifford C; Haney S; Klein MK; Beaver L; Vickery K; Vail DM; Hershey B; Ettinger S; Vaughan A; Alvarez F; Hillman L; Kiselow M; Thamm D; Higginbotham ML; Gauthier M; Krick E; Phillips B; Ladue T; Jones P; Bryan J; Gill V; Novasad A; Fulton L; Carreras J; McNeill C; Henry C; Gillings S
    Vet Comp Oncol; 2012 Sep; 10(3):194-205. PubMed ID: 22236194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat.
    Komatsu H; Ueshima A; Kobayashi Y; Shimoyama Y; Takiyama N; Rimpo K
    Clin Case Rep; 2023 Jun; 11(6):e7582. PubMed ID: 37334334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
    Holtermann N; Kiupel M; Hirschberger J
    Vet Comp Oncol; 2017 Jun; 15(2):632-640. PubMed ID: 26762970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.